FRAXIN
UNII V7M270Y072
Substance Identification & Data
This profile provides standardized clinical and technical data for Fraxin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V7M270Y072.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 524-30-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
V7M270Y072
524-30-1
N/A
Detailed Substance Profile
Preferred Name
FRAXIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C16H18O10 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
CRSFLLTWRCYNNX-QBNNUVSCSA-N Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c2c(O)c(OC)cc3ccc(=O)oc32
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Fraxin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Common Names & Synonyms
7,8-DIHYDROXY-6-METHOXYCOUMARIN 8-.BETA.-D-GLUCOPYRANOSIDE
FRAXETIN 8-.BETA.-D-GLUCOPYRANOSIDE
FRAXETOL 8-GLUCOSIDE
FRAXIN
FRAXIN [MI]
FRAXOSIDE
Systematic Nomenclature
2H-1-BENZOPYRAN-2-ONE, 8-(.BETA.-D-GLUCOPYRANOSYLOXY)-7-HYDROXY-6-METHOXY-